Newsroom

Macro and micro conditions in 2022 should be positive for credit markets, says Mohammed Kazmi, Portfolio Manager and Macro Strategist, in this podcast with Bernard McGrath, Senior Investment Specialist.

Hubbis (10.01.2022) - Having more than doubled its assets under management (AUM) since 2016, UBP's wealth and asset management businesses at the end of 2020 managed more than USD 30 billion across Asia.

The market for green and social bond issued by financial and non-financial companies is booming.

Despite waning global growth momentum and rising inflation, strong fundamentals and relative valuations are offering compelling arguments for a strategic allocation to emerging market fixed income.

Global consumers’ everyday lives are shaped by Swiss products and services at different levels and in various aspects. Our experts dive into the secret behind “Swiss-made” quality.

Le Temps (27.12.2021) - One fact about the financial industry that everyone agrees on nowadays is that, as a strategic allocator of private capital, it has a major role to play in reducing economies’ carbon footprint, and this is clear to see in the sharp growth of so-called “sustainable” funds.

The surge in inflation in 2021 combined with the sharp fall in unemployment leaves two of the US Federal Reserve’s key policy objectives within reach as the year comes to a close.

The global pandemic has allowed the European Union to lay a new foundation upon which it can build to bring about greater integration in the years ahead.

The Swiss small- and mid-cap (also known as “SMID-cap”) universe offers a balanced and diversified exposure to companies with long-term value-creation potential. Active managers can create significant added value through a disciplined stock-selection process.

Funds People (17.11.2021) - The rise of passive management, the difficulty of finding profitable, low-risk investments in a context of 0% interest rates, industry concentration and the ESG boom are just some of the challenges asset managers face. We spoke to Nicolas Faller, Co-CEO of Asset Management at Union Bancaire Privée, about all of this and more, in an exclusive interview. 

In the latest episode of UBP’s Expert series, Norman Villamin, CIO Wealth Management and Pierre Corby, Equity Analyst Healthcare, invited Dr Samarth Kulkarni, CEO of CRISPR Therapeutics, to discuss the challenges and investment opportunities offered by medical innovation, specifically in the field of gene editing.

Embracing Change